Cargando…

The impacts of surgery of the primary cancer and radiotherapy on the survival of patients with metastatic rectal cancer

The role of surgery of the primary cancer and radiation in metastatic colorectal cancer (mCRC) is still controversial currently, and evidence implied that colon cancer (CC) and rectal cancer (RC) should be treated with difference. Hence we focused on metastatic rectal cancer (mRC) solely to compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Duo, Liu, Fei, Li, Wenhua, Zhang, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687683/ https://www.ncbi.nlm.nih.gov/pubmed/29179513 http://dx.doi.org/10.18632/oncotarget.19157

Ejemplares similares

The survival impact of radiotherapy on synchronous metastatic rectal cancer: metastatic site can serve for radiotherapy-decision
por: Zhou, Yuan, et al.
Publicado: (2022)

Impact of peritoneal cytology on survival of endometrial cancer patients treated with surgery and radiotherapy
por: Tebeu, P M, et al.
Publicado: (2003)

The Effect of Interval From Completion of Short-Course Radiotherapy to Surgery on the Post-Operative Morbidity and Mortality of Patients with Rectal Cancer
por: Neely, T.D.A., et al.
Publicado: (2017)

Impact of neoadjuvant and adjuvant radiotherapy on disease-specific survival in patients with stages II–IV rectal cancer
por: Wu, Yinying, et al.
Publicado: (2017)

Increased number of negative lymph nodes is associated with improved cancer specific survival in pathological IIIB and IIIC rectal cancer treated with preoperative radiotherapy
por: Li, Qingguo, et al.
Publicado: (2014)

Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study
por: Luo, Dakui, et al.
Publicado: (2019)

Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Rectal Cancer
por: Attaallah, Wafi, et al.
Publicado: (2013)

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial
por: Loi, S, et al.
Publicado: (2005)

The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision
por: Xu, Biaoxiang, et al.
Publicado: (2022)

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
por: Liu, Qi, et al.
Publicado: (2019)

The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUV(max) on Predicting Survival in Patients with Rectal Cancer
por: Alçın, Göksel, et al.
Publicado: (2020)

Second primary malignancy risk after radiotherapy in rectal cancer survivors
por: Wang, Ti-Hao, et al.
Publicado: (2018)

Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery
por: Mikeljevic, J Stefoski, et al.
Publicado: (2004)

Incidence and risk factors for rectal pain after laparoscopic rectal cancer surgery
por: Lee, Jin Young, et al.
Publicado: (2017)

Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design
por: Li, Chao, et al.
Publicado: (2017)

Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma
por: Sanguineti, G, et al.
Publicado: (2002)

XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy
por: Qin, Chang-Jiang, et al.
Publicado: (2015)

A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer
por: Ngan, S Y K, et al.
Publicado: (2004)

Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992–2008
por: Lemmens, V. E. P. P., et al.
Publicado: (2011)

Biological effective dose evaluation and assessment of rectal and bladder complications for cervical cancer treated with radiotherapy and surgery
por: Beskow, Catharina, et al.
Publicado: (2012)

Radiotherapy for stage IIA rectal cancer may not benefit all
por: Hu, Xiang, et al.
Publicado: (2017)

p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis
por: Lopez-Crapez, E, et al.
Publicado: (2005)

Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed
por: Kunneman, M, et al.
Publicado: (2015)

Effect of interval between preoperative radiotherapy and surgery on clinical outcome and radiation proctitis in rectal cancer from FOWARC trial
por: Cheng, Yi‐Kan, et al.
Publicado: (2019)

A Single Centre Retrospective Evaluation of Laparoscopic Rectal Resection with TME for Rectal Cancer: 5-Year Cancer-Specific Survival
por: Quarati, Raoul, et al.
Publicado: (2011)

Improvement of Metastatic Spinal Cord Compression After Decompression Surgery and Radiotherapy in a Patient Initially Treated for Rectal Cancer
por: Utsumi, Nobuko, et al.
Publicado: (2022)

Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial
por: Bisceglia, Giovanni, et al.
Publicado: (2014)

Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer
por: Li, Wenhua, et al.
Publicado: (2017)

Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic setting
por: Repka, Michael C., et al.
Publicado: (2017)

Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer
por: Zhang, Li, et al.
Publicado: (2016)

Long-Term Survival with Regorafenib in KRAS-Mutated Metastatic Rectal Cancer
por: Amram, Marie-Laure, et al.
Publicado: (2017)

Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery
por: Li, Xiao-Fen, et al.
Publicado: (2017)

On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery
por: Glimelius, Bengt
Publicado: (2017)

Stereotactic MR-guided adaptive radiotherapy (SMART) for primary rectal cancer: evaluation of early toxicity and pathological response
por: Castelluccia, Alessandra, et al.
Publicado: (2023)

Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study
por: Kang, Yu‐Mei, et al.
Publicado: (2019)

Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences
por: Pieterse, A H, et al.
Publicado: (2007)

Survival benefit evaluation of radiotherapy in esophageal cancer patients aged 80 and older
por: Huang, Shan, et al.
Publicado: (2017)

Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer
por: Xu, Jing, et al.
Publicado: (2019)

A deep learning nomogram kit for predicting metastatic lymph nodes in rectal cancer
por: Ding, Lei, et al.
Publicado: (2020)

Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer
por: Wallis, C J D, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qaummmb40oo6b1hb17u9r5rn88